AlTamimi, A., AlGazlan, N. S., Aldawoud, M., Almazyad, A., Faqihi, F., Alwohaibi, A., Alghazi, B., Bakhribah, H., Rudaini, M., Alharbi, M., Abdullah, A. (2026). Real-world eligibility for adjuvant CDK4/6 therapy in HR+/HER2− early breast cancer: A comparative analysis of monarchE and NATALEE criteria from a single-institution cohort.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e12532